Bevacizumab in advanced cervical cancer

Clin Transl Oncol. 2014 Oct;16(10):935. doi: 10.1007/s12094-014-1205-7. Epub 2014 Sep 3.
No abstract available

Publication types

  • Letter

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Bevacizumab
  • Carcinoma / drug therapy*
  • Carcinoma / pathology
  • Female
  • Humans
  • Uterine Cervical Neoplasms / drug therapy*
  • Uterine Cervical Neoplasms / pathology

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab